| 1. | bklein64 | |
| 2. | srktlk | |
| 3. | rmekevincannon | |
| 4. | anthonyr394 | |
| 5. | plex76 |
Top Board Researchers
These are the top researchers based on quality of posts as voted by board members. Typically they know their stuff and are a great
way to catch up on what the company is all about.
HOW DO I BECOME ONE?
Just do great research! As other members approve of your posts, you earn points that move you up the ranks.| 1. | azweiso6 02/26/2018 Kyowa Kirin and Ultragenyx Announce Crysvita® (burosumab) Receives Conditional Marketing Authorization in Europe for the Treatment of X-Linked Hypophosphatemia in Children |
| 2. | srktlk 01/24/2018 Yeah. |
| 3. | bklein64 01/08/2018 News - Ultragenyx Announces Positive Interim Topline Results From First Cohort of Phase 1/2 Clinical Study of DTX301 Gene Therapy in Ornithine Transcarbamylase (OTC) Deficiency |
| 4. | cafereyes 01/29/2018 Ultragenyx Appoints Camille L. Bedrosian, M.D. as Chief Medical Officer and Executive Vice President |
| 5. | anthonyr394 01/24/2018 You dont see stocks go up often after an offering, I like it! |
| 6. | bklein64 02/21/2018 Stifel Nicolaus cuts price target to $74 from $85 |
| 7. | srktlk 02/21/2018 Morgan Stanley raises PT to $60 from $57 |
| 8. | bklein64 02/21/2018 Ultragenyx Reports Fourth Quarter and Full Year 2017 Financial Results and Corporate Update |
| 9. | azweiso6 05/07/2018 Beats EPS estimates by $0.81. Misses on revenues. |
| 10. | bklein64 01/24/2018 Ultragenyx Announces Proposed Public Offering of Common Stock |
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW
Ultragenyx Pharmaceutical Inc.
- RARE
- Public Stock Message Board
Filtering by:
-
To use your chart in a post, click the
icon above the chart. From there you can get the chart link or download the image.